Skip to main content
Figure 3 | Cardiovascular Diabetology

Figure 3

From: Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials

Figure 3

Incidence rate ratios for saxagliptin vs control (point estimates and 95% CI) for CV death, myocardial infarction, and stroke in the add-on to metformin study pool. Numbers in parentheses are total patient-years of exposure (the time up to an event or censoring). CV = cardiovascular; IRR = incidence rate ratio; SAXA = saxagliptin.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840